Skip to main content
logo
Mahamaya Lifesciences Limited (BOM:544611)
India flag India · Delayed Price · Currency is INR
183.00
-0.05 (-0.03%)
At close: Sep 25, 2026

Mahamaya Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
4,2843,522----
Market Cap Growth
------
Enterprise Value
4,7984,164----
Last Close Price
183.05150.50----

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
21.9821.32----
PS Ratio
1.301.07----
PB Ratio
3.512.89----
P/TBV Ratio
3.592.95----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
1.461.26----
EV/EBITDA Ratio
13.9112.07----
EV/EBIT Ratio
14.5912.67----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.740.741.182.201.251.22
Debt / EBITDA Ratio
2.632.632.424.222.633.05
Net Debt / Equity Ratio
0.420.421.102.081.101.13
Net Debt / EBITDA Ratio
1.491.492.253.982.302.83
Net Debt / FCF Ratio
-1.34-1.34-9.89-2.07-12.05-16.08
Asset Turnover
1.321.321.771.702.05-
Inventory Turnover
2.262.262.983.144.22-
Quick Ratio
0.630.630.400.400.270.35
Current Ratio
1.461.461.191.121.131.11
Return on Equity (ROE)
19.29%19.29%34.53%24.31%21.34%-
Return on Assets (ROA)
8.24%8.24%9.47%7.89%7.89%-
Return on Invested Capital (ROIC)
13.13%16.44%18.79%14.82%16.71%11.93%
Return on Capital Employed (ROCE)
25.90%25.90%40.10%35.20%27.90%21.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
3.86%4.69%----
FCF Yield
-8.95%-10.88%----
Buyback Yield / Dilution
-16.40%-16.40%-24.06%---